652 JOURNAL OF COSMETIC SCIENCE
(22) Sun J, Xia Y. Pretreating and normalizing metabolomics data for statistical analysis. Genes Dis. July
2024 11(3):100979. doi:10.1016/j.gendis.2023.04.018
(23) Walczak-Skierska J, Monedeiro F, Maślak E, Złoch M. Lipidomics characterization of the microbiome
in people with diabetic foot infection using MALDI-TOF MS. Anal Chem. 2023 95(44):16251–16262.
doi:10.1021/acs.analchem.3c03071
(24) Holčapek M, Liebisch G, Ekroos K. Lipidomic analysis. Anal Chem. 2018 90(7):4249–4257. doi:10.1021/
acs.analchem.7b05395
(25) Sinha S, Lin G, Ferenczi K. The skin microbiome and the gut-skin axis. Clin Dermatol. 2021 39(5):829–839.
doi:10.1016/j.clindermatol.2021.08.021
(26) Salem I, Ramser A, Isham N, Ghannoum MA. The gut microbiome as a major regulator of the gut-skin
axis. Front Microbiol. July 2018 9:1459. doi:10.3389/fmicb.2018.01459
(27) Greene AK, Nelson AM. The gut microbiome in melanoma: A piece of a complex puzzle. JAMA
Dermatol. 2023 159(10):1044–1046. doi:10.1001/jamadermatol.2023.2952
(28) Maguire M, Maguire G. The role of microbiota, and probiotics and prebiotics in skin health. Arch
Dermatol Res. 2017 309(6):411–421. doi:10.1007/s00403-017-1750-3
(29) Codoñer FM, Ramírez-Bosca A, Climent E, et al. Gut microbial composition in patients with psoriasis.
Sci Rep. February 2018 8(1):3812. doi:10.1038/s41598-018-22125-y
(30) O’Neill CA, Monteleone G, McLaughlin JT, Paus R. The gut-skin axis in health and disease: A paradigm
with therapeutic implications. BioEssays. 2016 38(11):1167–1176. doi:10.1002/bies.201600008
(31) Stec A, Sikora M, Maciejewska M, et al. Bacterial metabolites: A link between gut microbiota and
dermatological diseases. Int J Mol Sci. February 2023 24(4). doi:10.3390/ijms24043494
(32) Tan J, McKenzie C, Potamitis M, et al. Insights into the gut-skin axis: implications for skin disorders.
Clin Microbiol Rev. 2018 31:e00101–18.
(33) Cummings JH, Macfarlane GT. Role of intestinal bacteria in nutrient metabolism. Clin Nutr.
1997 16:3–11.
(34) Chakraborty P, Banerjee D, Majumder P, Sarkar J. Gut microbiota nexus: exploring the interactions
with the brain, heart, lungs, and skin axes and their effects on health, Med. Microecol. March 2024 20.
(35) Kimura I, Ichimura A, Ohue-Kitano R, Igarashi M. Free fatty acid receptors in health and disease.
Physiol Rev. 2020 100(1):171–210. doi:10.1152/physrev.00041.2018
(36) Jiminez V, Yusuf N. Bacterial metabolites and inflammatory skin diseases. Metabolites. August 2023 13(8).
doi:10.3390/metabo13080952
(37) Huang Y, Liu L, Hao Z, et al. Potential roles of gut microbial tryptophan metabolites in the complex
pathogenesis of acne vulgaris. Front Microbiol. July 2022 13:942027. doi:10.3389/fmicb.2022.942027
(38) Roager HM, Licht TR. Microbial tryptophan catabolites in health and disease. Nat Commun. August
2018 9(1):3294. doi:10.1038/s41467-018-05470-4
(39) Jennis M, Cavanaugh CR, Leo GC, Mabus JR, Lenhard J, Hornby PJ. Microbiota-derived tryptophan
indoles increase after gastric bypass surgery and reduce intestinal permeability in vitro and in vivo.
Neurogastroenterol Motil. August 2018 30(2). doi:10.1111/nmo.13178
(40) Esser C, Rannug A. The aryl hydrocarbon receptor in barrier organ physiology, immunology, and
toxicology. Pharmacol Rev. 2015 67(2):259–279. doi:10.1124/pr.114.009001
(41) Yu J, Luo Y, Zhu Z, et al. A tryptophan metabolite of the skin microbiota attenuates inflammation
in patients with atopic dermatitis through the aryl hydrocarbon receptor. J Allergy Clin Immunol.
2019 143:2108–2119.e12.
(42) Liu X, Zhang X, Zhang J, et al. Activation of aryl hydrocarbon receptor in Langerhans cells by a microbial
metabolite of tryptophan negatively regulates skin inflammation. J Dermatol Sci. 2020 100(3):192–200.
doi:10.1016/j.jdermsci.2020.10.004
(43) Jux B, Kadow S, Luecke S, Rannug A, Krutmann J, Esser C. The aryl hydrocarbon receptor mediates
UVB radiation-induced skin tanning. J Invest Dermatol. 2011 131(1):203–210. doi:10.1038/jid.2010.269

653 Bidirectional Gut-Skin Axis
(44) Murai M, Yamamura K, Hashimoto-Hachiya A, Tsuji G, Furue M, Mitoma C. Tryptophan photo-
product FICZ upregulates AHR/MEK/ERK-mediated MMP1 expression: implications in anti-fibrotic
phototherapy. J Dermatol Sci. 2018 91(1):97–103. doi:10.1016/j.jdermsci.2018.04.010
(45) Fernández-Gallego N, Sánchez-Madrid F, Cibrian D. Role of AHR ligands in skin homeostasis and
cutaneous inflammation. Cells. November 2021 10(11). doi:10.3390/cells10113176
(46) Poormasjedi-Meibod M-S, Hartwell R, Kilani RT, Ghahary A. Anti-scarring properties of different
tryptophan derivatives. PLOS ONE. March 2014 9(3):e91955. doi:10.1371/journal.pone.0091955
(47) Aoki R, Aoki-Yoshida A, Suzuki C, Takayama Y. Protective effect of indole-3-pyruvate against
ultraviolet B-induced damage to cultured HaCaT keratinocytes and the skin of hairless mice. PLOS
ONE. May 2014 9(5):e96804. doi:10.1371/journal.pone.0096804
(48) Gatarek P, Kaluzna-Czaplinska J. Trimethylamine N-oxide (TMAO) in human health. Excli J.
2021 20:301–319. doi:10.17179/excli2020-3239
(49) Liu Y, Dai M. Trimethylamine N-oxide generated by the gut microbiota is associated with vascular
inflammation: new insights into atherosclerosis. Mediators Inflamm. 2020 (February 2020) 2020:4634172.
doi:10.1155/2020/4634172
(50) Sikora M, Kiss N, Stec A, et al. Trimethylamine N-oxide, a gut microbiota-derived metabolite, is
associated with cardiovascular risk in psoriasis: A cross-sectional pilot study. Dermatol Ther (Heidelb).
2021 11(4):1277–1289. doi:10.1007/s13555-021-00547-3
(51) Barrea L, Muscogiuri G, Pugliese G, et al. Association of trimethylamine N-oxide (TMAO) with the clinical
severity of hidradenitis suppurativa (acne inversa). Nutrients. June 2021 13(6). doi:10.3390/nu13061997
(52) Akiyama T, Iodi Carstens M, Carstens E. Transmitters and pathways mediating inhibition of spinal
itch-signaling neurons by scratching and other counterstimuli. PLOS ONE. July 2011 6(7):e22665.
doi:10.1371/journal.pone.0022665
(53) Langan EA, Lisztes E, Bíró T, et al. Dopamine is a novel, direct inducer of catagen in human scalp hair
follicles in vitro. Br J Dermatol. 2013 168(3):520–525. doi:10.1111/bjd.12113
(54) Lee HJ, Park MK, Kim SY, Park Choo HYP, Lee AY, Lee CH. Serotonin induces melanogenesis via
serotonin receptor 2A. Br J Dermatol. 2011 165(6):1344–1348. doi:10.1111/j.1365-2133.2011.10490.x
(55) Yokoyama S, Hiramoto K, Koyama M, Ooi K. Impairment of skin barrier function via cholinergic signal
transduction in a dextran sulphate sodium-induced colitis mouse model. Exp Dermatol. 2015 24(10):779–
784. doi:10.1111/exd.12775
(56) Humbert P, Pelletier F, Dreno B, Puzenat E, Aubin F. Gluten intolerance and skin diseases. Eur J
Dermatol. 2006 16(1):4–11.
(57) Lupu VV, Jechel E, Mihai CM, et al. Connection between celiac disease and systemic lupus erythematosus
in children—A development model of autoimmune diseases starting from what we inherit to what we
eat. Nutrients. May 2023 15(11). doi:10.3390/nu15112535
(58) Cardona F, Andrés-Lacueva C, Tulipani S, Tinahones FJ, Queipo-Ortuño MI. Benefits of polyphenols on
gut microbiota and implications in human health. J Nutr Biochem. 2013 24(8):1415–1422. doi:10.1016/j.
jnutbio.2013.05.001
(59) Giampieri F, Alvarez-Suarez JM, Mazzoni L, et al. Polyphenol-rich strawberry extract protects
human dermal fibroblasts against hydrogen peroxide oxidative damage and improves mitochondrial
functionality. Molecules. 2014 19(6):7798–7816. doi:10.3390/molecules19067798
(60) Williams HC, Dellavalle RP, Garner S. Acne vulgaris. Lancet. 2012 379(9813):361–372. doi:10.1016/
S0140-6736(11)60321-8
(61) Bowe WP, Logan AC. Acne vulgaris, probiotics and the gut-brain-skin axis—Back to the future? Gut
Pathog. January 2011 3(1):1. doi:10.1186/1757-4749-3-1
(62) Huang S, Rutkowsky JM, Snodgrass RG, et al. Saturated fatty acids activate TLR-mediated
proinflammatory signaling pathways. J Lipid Res. 2012 53(9):2002–2013. doi:10.1194/jlr.D029546
(63) Mahmood SN, Bowe WP. Diet and acne update: carbohydrates emerge as the main culprit. J Drugs
Dermatol. 2014 13(4):428–435.